COVID-19 | Specialty

COVID-19: The Unexpected Sequelae

May 12th 2020

History will report that the COVID-19 pandemic in Brooklyn, New York peaked on or about April 12, 2020; however, due to the protracted hospitalization experienced by severe COVID-19–positive patients, the heavy in-patient burden continues today.

Dr. Trent on the Impact of COVID-19 on the Treatment of Rare Cancers

May 12th 2020

Jonathan C. Trent, MD, PhD, sheds light on the impact of COVID-19 on the treatment of rare cancers.

Brufsky Theorizes How Molecular Interaction Could Lead to COVID-19 Infection

May 12th 2020

Adam M. Brufsky, MD, PhD, discusses the impact of the COVID-19 pandemic on patients with cancer, as well as the science behind the proposed explanation of the immunopathology of COVID-19.

OncLive Saturday Spotlight: A Morning With The University of Chicago Medicine

May 12th 2020

OncLive Saturday Spotlight: A Morning With NYU Langone-Perlmutter Cancer Center

May 12th 2020

The State of Ovarian Cancer: Exploring the Landscape of Systemic Therapy

May 11th 2020

The State of Ovarian Cancer: Surgical Practices and Management

May 11th 2020

The State of Ovarian Cancer: How Ovarian Cancer Care is Evolving in the COVID-19 Pandemic

May 11th 2020

SGO COVID-19 Task Force Provides Guidance During "Our Version of the Great Depression"

May 11th 2020

Warner K. Huh, MD, discusses the management of gynecologic cancers during the COVID-19 era, the SGO COVID-19 task force, and what is needed to quell the pandemic, which he refers to as our version of the Great Depression.

Evolutions in Hepatocellular Carcinoma in the Era of COVID-19

May 7th 2020

AI System Helps Guide Care for High-Risk Patients in Oncology

May 6th 2020

In an era of value-based care, the ability to triage the needs of patients with cancer who are most likely to experience significant difficulties is becoming a priority for community oncology practices and hospital systems.

Dr. Ocean on Combating the Emotional Toll Caused by COVID-19 in Cancer

May 6th 2020

Allyson Ocean, MD, discusses the emotional toll COVID-19 has had on patients and practitioners in the oncology space and the importance of self-care and social distancing.

Dr. Desai Sheds Light on COVID-19 Risk Among Patients With Cancer

May 5th 2020

Aakash Desai, MD, MPH, provides additional insight into his research on COVID-19 risk and patients with cancer and shed light on how institutions are taking action against the virus.

The Uromigos Unveil Updates and Insights on the Impact of COVID-19 on GU Cancers

May 4th 2020

In an effort to share some of the evolving knowledge about COVID-19 and how it is impacting the healthcare system on a global scale, the Uromigos group discusses statistics, strategies, and new studies as they relate to COVID-19 and patients with genitourinary cancers.

Dr. Saba on the Impact of COVID-19 on Telehealth in Head and Neck Cancer

May 4th 2020

Nabil F. Saba, MD, FACP, director, Head and Neck Medical Oncology Program, Winship Cancer Institute of Emory University, professor, Department of Hematology and Medical Oncology, Department of Otolaryngology, Emory University School of Medicine, discusses the impact of the coronavirus disease 2019 (COVID-19) on telehealth in head and neck cancer.

Close Call: Oncologist on Her COVID-19 Test and How Health Care Has Changed Forever

May 1st 2020

Narjust Duma, MD, shares her experience with being tested for COVID-19 and discusses the lasting implications of the pandemic.

Overcoming the Emotional Toll of COVID-19 in Oncology

May 1st 2020

Allyson Ocean, MD, discusses the emotional toll COVID-19 has had on patients and practitioners and the importance of self-care and social distancing.

Dr. O'Regan on Breast Cancer Treatment Considerations During the COVID-19 Crisis

May 1st 2020

Ruth O’Regan, MD, provides insight on how the COVID-19 crisis is impacting the care of patients with breast cancer.

COVID-19 Causes Major Treatment Modifications in Head and Neck Cancer

April 30th 2020

Nabil F. Saba, MD, FACP, discusses how the COVID-19 pandemic has impacted treatment in head and neck cancer and the health care system at large.

No COVID-19 Detour for Global Hematology Therapies

April 29th 2020

With travel restrictions and reduced transportation options, the global spread of coronavirus disease 2019 has disrupted international networks that supply patients with biological materials needed for sophisticated hematologic therapies.